SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $326,688 | +45.8% | 2,695 | +55.9% | 0.31% | +201.0% |
| Q4 2022 | $224,044 | -48.7% | 1,729 | -70.3% | 0.10% | -49.0% |
| Q2 2022 | $437,000 | -51.4% | 5,826 | -41.6% | 0.20% | -56.0% |
| Q4 2021 | $899,000 | +162.9% | 9,981 | +367.7% | 0.46% | +99.6% |
| Q2 2020 | $342,000 | +1.5% | 2,134 | -18.4% | 0.23% | +31.8% |
| Q4 2019 | $337,000 | +81.2% | 2,614 | +5.7% | 0.17% | +183.6% |
| Q3 2019 | $186,000 | – | 2,473 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |